Citadel Advisors’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,600
Closed -$344K 13116
2025
Q2
$344K Sell
4,600
-3,800
-45% -$294K ﹤0.01% 9483
2025
Q1
$681K Buy
8,400
+6,000
+250% +$523K ﹤0.01% 7799
2024
Q4
$214K Buy
2,400
+2,300
+2,300% +$232K ﹤0.01% 10321
2024
Q3
$11.5K Sell
100
-300
-75% -$31.4K ﹤0.01% 13154
2024
Q2
$38K Sell
400
-5,600
-93% -$505K ﹤0.01% 12033
2024
Q1
$496K Buy
6,000
+1,200
+25% +$99.2K ﹤0.01% 8422
2023
Q4
$423K Buy
4,800
+4,400
+1,100% +$360K ﹤0.01% 8458
2023
Q3
$34.2K Sell
400
-1,600
-80% -$145K ﹤0.01% 12168
2023
Q2
$187K Buy
2,000
+1,100
+122% +$103K ﹤0.01% 9999
2023
Q1
$89.7K Sell
900
-9,300
-91% -$946K ﹤0.01% 11418
2022
Q4
$1.01M Buy
+10,200
New +$991K ﹤0.01% 6797
2022
Q1
Sell
-2,500
Closed -$292K 13863
2021
Q4
$292K Sell
2,500
-2,000
-44% -$235K ﹤0.01% 10986
2021
Q3
$509K Sell
4,500
-3,100
-41% -$334K ﹤0.01% 9817
2021
Q2
$678K Buy
+7,600
New +$712K ﹤0.01% 9313

Other funds holding EXPO

Citadel Advisors's EXPO Position: Q1 2026 in Review

Citadel Advisors reduced its Exponent (EXPO) stake by 84% in Q1 2026, selling an estimated $14.2M and leaving 36,817 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #5703.

Citadel Advisors first reported a position in EXPO in Q2 2013 and has held it in 38 quarters since. The position peaked at $25.3M in Q1 2023. 360 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • Citadel Advisors held 36,817 shares of Exponent worth $2.4M as of Q1 2026.
  • Citadel Advisors sold 200,303 Exponent shares in Q1 2026, an estimated $14.2M.
  • Exponent made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5703 holding.
  • Citadel Advisors first reported a position in Exponent in Q2 2013 and has held it in 38 quarters since.
  • Citadel Advisors's Exponent position peaked at $25.3M in Q1 2023.
  • 360 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.